Skip to main content
. 2022 Jul 15;27(14):4521. doi: 10.3390/molecules27144521

Figure 9.

Figure 9

Growth inhibition of MCF-7 human BC and REF normal cell lines treated with different concentrations (3.1, 6.25, 12.5, 25 and 50 μg mL−1) of galangin and GAL/β-CD. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. ns, non-significant.